US Roadside Drug Testing Market Trend Analysis Report

Dublin, September 20, 2024 (GLOBE NEWSWIRE) — The report “US Roadside Drug Testing Market Size, Share & Trends Analysis Report By Drug (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamines & Methamphetamines, LSD), By Sample, By Test Location, By States, And Segment Forecasts, 2024 – 2030” has been added to The Offer.

The US roadside drug testing market is expected to reach $1.62 billion by 2030, growing at a compound annual growth rate of 4.71% from 2024 to 2030.

The roadside drug testing market in the United States is experiencing significant growth, driven by the increasing legalization of recreational cannabis and the rise in drug-driving cases. As states legalize marijuana, law enforcement agencies are facing new challenges in ensuring road safety. This has led to a rise in demand for modern roadside drug tests that can quickly and accurately detect various substances.

Traditional methods such as urine and blood tests are being supplemented by more efficient technologies, such as oral fluid tests, which are non-invasive and provide instant results. One of the latest developments is the integration of artificial intelligence (AI) into these devices, improving their accuracy and reducing human error. Portable breathalyzers that can detect both alcohol and drugs are also becoming more common. In addition, research is being conducted into devices that can measure not only the presence of drugs but also impairment, to address the issue of varying tolerance levels among individuals.

This market is further bolstered by government initiatives and funding. The National Highway Traffic Safety Administration (NHTSA) and other agencies are investing in developing more sophisticated testing tools. As the U.S. continues to grapple with the complexities of driving under the influence, the roadside drug testing market is expected to grow, with innovations focused on improving detection capabilities and ensuring the safety of all road users.

Highlights of the US Roadside Drug Testing Market Report

• The alcohol segment accounted for the largest share of revenue in 2023. Alcohol testing continues to dominate the market because alcohol impairment has long been viewed as a significant safety risk, clearly defined legal limits exist, and standardized devices such as breathalyzers are widely used for accurate and reliable testing.
• The breath segment accounted for the largest revenue share in 2023. Breath tests are the most commonly used method to determine alcohol impairment because they are quick, non-invasive and provide instant results. Breathalyzers are portable, making them convenient for use by police officers during roadside checks.
• The highway patrol division had the largest revenue share in 2023. These officers are often the first responders at the scene of traffic stops, accidents, and roadside checks where driving under the influence of alcohol is a significant problem.

Featured companies

• Drägerwerk AG & Co. KGaA
• Abbott.
• Intoximeter
• Lifeloc Technologies, Inc.
• Hound Labs, Inc.
• Immunolysis Corporation
• CMI Inc.
• Alcohol Countermeasure Systems Corp.
• AK GlobalTech Corp.
• PAS Systems International, Inc

Main features:

Main topics covered:

Chapter 1. Methodology and scope

Chapter 2. Summary
2.1. Market outlook
2.2. Segment outlook
2.2.1. Drug and sample outlook
2.2.2. Outlook on the test site
2.2.3. Regional outlook
2.3. Insights into the competition

Chapter 3. Variables, trends and scope of the US roadside drug testing market
3.1. Market outlook
3.1.1. Market outlook for the parent company
3.1.2. Related/complementary market prospects
3.2. Market dynamics
3.2.1. Market driver analysis
3.2.1.1. Increase in deaths and accidents due to alcohol/drug abuse among drivers
3.2.1.2. Increased routine police checks
3.2.1.3. Rapid increase in the consumption of illegal substances
3.2.2. Analysis of market restrictions
3.2.2.1. High costs for test equipment
3.3. Analysis tools for the US street drug testing market
3.3.1. Industry analysis – Porter’s five forces
3.3.2. PESTEL analysis
3.3.3. Opportunity analysis
3.3.4. Spending structure for roadside drug testing by state
3.3.5. Landscape of strategic initiatives
3.3.6. Regulatory landscape by state taking into account current competition
3.3.7. BY STATE, BY CITY, BY MUNICIPALITY
3.3.8. California
3.3.9. Texas
3.3.10.Florida
3.3.11.New York
3.3.12. Pennsylvania
3.3.13. Illinois
3.3.14. Ohio
3.3.15. Georgia
3.3.16.North Carolina
3.3.16.1. Penetration index by state
3.3.16.2. Drug-driving statistics by state
3.3.16.3. Dre landscape and statistics
3.3.16.4. Dre Training Stats, 2018-2023
3.3.16.5. Number of dre by category by state
3.3.16.6. Qualitative landscape by state
3.3.16.7. Case studies by state

Chapter 4. US Roadside Drug Testing Market: Drug Market Estimates and Trend Analysis
4.1. US roadside drug testing market: Drug Dashboard
4.2. US roadside drug testing market: drug movement analysis
4.3. US roadside drug testing market by drug, revenue
4.4. Alcohol
4.4.1. Estimates and forecasts for the alcohol market 2018 to 2030 (in million USD)
4.5. Cannabis/Marijuana
4.6. Cocaine
4.7. Opioids
4.8. LSD
4.9. Miscellaneous

Chapter 5. US Roadside Drug Testing Market: Sample Estimates and Trend Analysis
5.1. US Roadside Drug Testing Market: Example Dashboard
5.2. US Roadside Drug Testing Market: Pattern Movement Analysis
5.3. US roadside drug testing market by sample and revenue
5.4. Saliva
5.5. Breathing
5.6. Urin
5.7. Blood

Chapter 6. US Roadside Drug Testing Market: Testing Location Estimates and Trend Analysis
6.1. US Roadside Drug Testing Market: Testing Site Dashboard
6.2. US roadside drug testing market: analysis of testing site movement
6.3. US roadside drug testing market by testing location, revenue
6.4. Motorway police
6.5. Drug control authorities

Chapter 7. US Roadside Drug Testing Market: Regional Estimates and Trend Analysis by Drug, Sample and Test Location
7.1. Regional Dashboard
7.2. Market size and forecast trend analysis, 2018 to 2030

Chapter 8. Competitive landscape
8.1. Current developments and impact analysis by key market participants
8.2. Categorization of companies/competitors
8.3. Provider landscape
8.3.1. List of key distributors and sales partners
8.3.2. Key customers
8.3.3. Market share analysis of major companies, 2023

For more information about this report, see

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

• Roadside drug testing market in the US